Ads
related to: vertex pharmaceuticals- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Find all the ways to reach us
for the information you need.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Our Company
Search results
Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by StockNews.com
ETF DAILY NEWS· 5 days agoBarclays lifted their target price on Vertex Pharmaceuticals from $446.00 to $472.00 and gave the stock an “overweight” rating in a report on Tuesday, February ...
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its...
Simply Wall St. via Yahoo Finance· 6 days agoAs you might know, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) just kicked off its latest...
Unveiling Vertex Pharmaceuticals (VRTX)'s Market Value: A Compre
Guru Focus· 24 hours agoVertex Pharmaceuticals Inc (VRTX, Financial) recently reported a daily loss of 1.32%, reflecting a slight dip in its stock price, yet it has gained 1.74% ...
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy | The...
The Motley Fool· 3 days agoVertex Pharmaceuticals is making steady progress toward earning approval for a new CF medicine....
Vertex Stock Hit All-Time High, Paused, Rising Again
Investor's Business Daily· 22 hours agoHighly rated Vertex Pharmaceuticals (VRTX) continues to trade near its all-time high. The upgraded Relative Strength Rating shows that Vertex stock tops...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 24 minutes agoMeanwhile, the company's Casgevy treatment for sickle cell anemia, developed in partnership with ...
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
Zacks via Yahoo Finance· 1 day agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
Vertex Is Writing A New Playbook For Pharma R&D. And It’s Working.
Forbes· 1 day ago...Sovaldi in December 2013 directly causing Incivek’s commercial flameout, Jeff Leiden, M.D.,...
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Ami
Guru Focus· 5 days agoThis announcement comes in the wake of a significant development where Vertex Pharmaceuticals Incorporated agreed to acquire Alpine for $65 per share in ...
Ad
related to: vertex pharmaceuticals